No Photo Available

Last Update

2017-02-21T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Howard Rosen?

Mr. Howard M. Rosen

Vice President, Cell Processing

Haemonetics Corporation

Direct Phone: (781) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Haemonetics Corporation

400 Wood Road

Braintree, Massachusetts 02184

United States

Company Description

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses importan ... more

Find other employees at this company (3,434)

Background Information

Employment History

Vice President, Sales and Marketing

BG Medicine Inc

Director, Cardiovascular Service Line Franchise, CRV

Boston Scientific Corporation

Education

B.S.

Business Administration

Northeastern University

Web References (5 Total References)


Management | BG Medicine Corporate Site

investor.bg-medicine.com [cached]

Howard Rosen Vice President, Sales and Marketing

Mr. Rosen joins BG Medicine from a two decade tenure in Sales and Marketing with Boston Scientific, where he most recently held the position of Director, Cardiovascular Service Line Franchise in the Cardiology, Rhythm and Vascular (CRV) Division where he led marketing strategies and channel activities. Previously at Boston Scientific, he held positions of increasing responsibility, including sales, product management, Group Marketing Manager, Director, and Global Carotid Endovascular Therapies for the Medi-tech and Peripheral Vascular Divisions. Prior to Boston Scientific, Mr. Rosen held sales and product management roles with Medi-tech. Mr. Rosen holds a B.S. in Business Administration from Northeastern University.


Howard Rosen Vice ...

www.galectin-3.com [cached]

Howard Rosen Vice President, Sales and Marketing

...
Howard Rosen Vice President, Sales and Marketing
Mr. Rosen joins BG Medicine from a two decade tenure in Sales and Marketing with Boston Scientific, where he most recently held the position of Director, Cardiovascular Service Line Franchise in the Cardiology, Rhythm and Vascular (CRV) Division where he led marketing strategies and channel activities. Previously at Boston Scientific, he held positions of increasing responsibility, including sales, product management, Group Marketing Manager, Director, and Global Carotid Endovascular Therapies for the Medi-tech and Peripheral Vascular Divisions. Prior to Boston Scientific, Mr. Rosen held sales and product management roles with Medi-tech. Mr. Rosen holds a B.S. in Business Administration from Northeastern University.


ImagingBIz.com E-Newsletter - Volume 2, Number 4

www.imagingcenterinstitute.com [cached]

Quoting Howard Rosen of Boston Scientific, the article states that Medicare covers just 5% to 7% of beneficiaries with carotid artery disease, and that the expanded coverage would include between 15% and 20% of beneficiaries.


Under current policy, Medicare covers the ...

video.clintonglobalinitiative.org [cached]

Under current policy, Medicare covers the new procedure for between 5% and 7% of beneficiaries with carotid artery disease, and the expansion under consideration by CMS would increase the rate to between 15% and 20%, according to Howard Rosen, director of the carotid endovascular program at Boston Scientific.


Use of stents in the carotid ...

www.twincities.com [cached]

Use of stents in the carotid artery is just the latest migration of stent technology from the coronary artery to important arteries outside or "peripheral" to the heart, said Howard Rosen, director of the carotid endovascular program at Boston Scientific Corp.Rosen estimated that the overall market for stents in neck arteries eventually might reach $1 billion in value, although current sales are much lower.

Similar Profiles

Other People with this Name

Other people with the name Rosen

Brittany Rosen
University of Cincinnati

Alyson Rosen
Ink Publishing

Bruce Rosen
EisnerAmper LLP

Matthew Rosen
Davies Ward Phillips & Vineberg LLP

Tara Rosen
Equipment Journal

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory